122 related articles for article (PubMed ID: 28133262)
1. [A Case of Recurrent Esophagogastric Junction Cancer Responding to Trastuzumab].
Kobayashi Y; Hirao M; Yamamoto K; Nishikawa K; Maeda S; Uemura M; Miyake M; Hama N; Miyamoto A; Miyazaki M; Ikeda M; Nakamori S; Sekimoto M; Mori K; Mano M
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2181-2183. PubMed ID: 28133262
[TBL] [Abstract][Full Text] [Related]
2. [A case of HER2-positive esophagogastric junction cancer treated by using a neoadjuvant chemotherapy regimen consisting of trastuzumab].
Kanaya N; Arata T; Tanakaya K; Yamasaki R; Aoki H; Takeuchi H
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2285-6. PubMed ID: 25731497
[TBL] [Abstract][Full Text] [Related]
3. [A Case of HER2-Positive Siewert Type I Adenocarcinoma of the Esophagogastric Junction Treated via Neoadjuvant Chemotherapy Followed by Radical Resection].
Nakajima T; Sato T; Kano K; Maezawa Y; Segami K; Fujikawa H; Ikeda K; Yamada T; Ogata T; Cho H; Yoshikawa T
Gan To Kagaku Ryoho; 2016 Oct; 43(10):1240-1242. PubMed ID: 27760947
[TBL] [Abstract][Full Text] [Related]
4. [A case of advanced esophagogastric junction cancer responding to pre-operative combination chemotherapy of docetaxel, cisplatin, S-1, and trastuzumab].
Haruki S; Takiguchi N; Arita K; Usui S; Ito K; Matsumoto A; Hiranuma S; Bhunachet E
Gan To Kagaku Ryoho; 2013 Aug; 40(8):1089-92. PubMed ID: 23986058
[TBL] [Abstract][Full Text] [Related]
5. [A Case of Successful Multidisciplinary Therapy for Advanced Esophagogastric Junction Cancer with Multiple Lymph Node Metastase].
Murakami K; Tamura S; Takeno A; Ishida T; Kuwahara R; Akiyama Y; Sakamoto T; Inatome J; Naito A; Katsura Y; Ohmura Y; Kagawa Y; Egawa C; Takeda Y; Kato T
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2010-2012. PubMed ID: 28133205
[TBL] [Abstract][Full Text] [Related]
6. [A case of mixed adenoneuroendocrine carcinoma of the esophagogastric junction treated with neoadjuvant chemotherapy].
Nakai M; Kawasaki H; Wajima N; Kimura A; Nakayama Y; Muroya T; Yonaiyama S; Okano K; Nagase H; Hakamada K
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2301-3. PubMed ID: 24394092
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction.
Phillips BE; Tubbs RR; Rice TW; Rybicki LA; Plesec T; Rodriguez CP; Videtic GM; Saxton JP; Ives DI; Adelstein DJ
Dis Esophagus; 2013 Apr; 26(3):299-304. PubMed ID: 22676551
[TBL] [Abstract][Full Text] [Related]
8. [A clinical case of lymph node recurrence after the resection of esophagogastric junction cancer treated by chemoradiation therapy].
Oohinata R; Iwasaki Y; Oohashi M; Iwanaga T; Takahashi K; Yamaguchi T; Matsumoto H; Nakano D
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2378-80. PubMed ID: 23268083
[TBL] [Abstract][Full Text] [Related]
9. [A Case of HER2-Positive Esophagogastric Junction Cancer with Perforation Curatively Resected after Neoadjuvant Chemotherapy plus Trastuzumab].
Toshima H; Hisamatsu A; Shimada K; Saito M; Suzuki M; Matsukawa M; Inoue H
Gan To Kagaku Ryoho; 2016 Jun; 43(6):761-4. PubMed ID: 27306816
[TBL] [Abstract][Full Text] [Related]
10. [A case of adenosquamous carcinoma at the esophagogastric junction, initially diagnosed as collision carcinoma].
Sasaki Y; Harada M; Kurosaki S; Shimada Y; Hayashi M; Kamiichi H; Kawamura N; Kajiyama Y; Yao T
Nihon Shokakibyo Gakkai Zasshi; 2015 May; 112(5):848-55. PubMed ID: 25947020
[TBL] [Abstract][Full Text] [Related]
11. [Remarkable Response to Trastuzumab Observed in a Case of Gastric Cancer with HER2-Negative Conversion].
Horii N; Morioka D; Yamaguchi K; Sato Y
Gan To Kagaku Ryoho; 2016 Oct; 43(10):1207-1209. PubMed ID: 27760939
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival after immunotherapy and targeted therapy without chemotherapy in an elderly patient with HER2-positive gastroesophageal junction cancer: A case report.
Li WL; Zhang Y; Zhang XL; Du YY; Hu WQ; Zhao J
Hum Vaccin Immunother; 2022 Nov; 18(6):2121109. PubMed ID: 36166751
[TBL] [Abstract][Full Text] [Related]
13. [A case of AFP-producing esophagogastric junction cancer with liver metastases with a good response to chemotherapy].
Nagai Y; Kato T; Harano M; Satoh D; Choda Y; Tokumoto N; Kanazawa T; Matsukawa H; Ojima Y; Idani H; Shiozaki S; Okajima M; Ninomiya M; Ohno S
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2349-51. PubMed ID: 25731519
[TBL] [Abstract][Full Text] [Related]
14. [A Case of Meningeal Carcinomatosis following Esophagogastric Junction Cancer Surgery].
Arai T; Komori K; Urata N; Uchiyama M; Suzuki Y; Rino Y; Saito A
Gan To Kagaku Ryoho; 2024 Jan; 51(1):78-80. PubMed ID: 38247098
[TBL] [Abstract][Full Text] [Related]
15. [Hepatic Resection of Multiple Liver Metastases from Gastric Cancer after Molecular Targeted Chemotherapy(S-1 plus Cisplatin plus Trastuzumab)].
Kim Y; Hosoda Y; Nishino M; Okano M; Kawada J; Yamasaki M; Nagai K; Yasui M; Okuyama M; Tsujinaka T
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1635-7. PubMed ID: 26805121
[TBL] [Abstract][Full Text] [Related]
16. [A Case of Esophagogastric Junction Cancer Treated Successfully with Conversion Surgery after Complete Response to Nivolumab Treatment].
Yamazaki K; Taniguchi K; Yamane M; Hattori Y; Koizumi A; Shigehara F; Takashima J; Sugimoto H; Miura F; Matsutani N; Kobayashi H
Gan To Kagaku Ryoho; 2021 Dec; 48(13):2121-2123. PubMed ID: 35045512
[TBL] [Abstract][Full Text] [Related]
17. [Trastuzumab in combination with chemotherapy versus chemotherapy alone for first-line treatment of HER2-positive advanced gastric or gastroesophageal junction cancer: a Phase III, multi-center, randomized controlled trial, Chinese subreport].
Shen L; Xu JM; Feng FY; Jiao SC; Wang LW; Li J; Guan ZZ; Qin SK; Wang JJ; Yu SY; Wang YJ; Jin YN; Tao M; Zheng LZ; Pan LX
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):295-300. PubMed ID: 23985260
[TBL] [Abstract][Full Text] [Related]
18. [A Case of HER2-Positive Advanced Gastric Cancer with a Pathological Complete Response to Neoadjuvant Chemotherapy with S-1/CDDP/Trastuzumab].
Nishino M; Hosoda Y; Okano M; Nagai K; Yasui M; Kim Y; Tsujinaka T
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2043-5. PubMed ID: 26805258
[TBL] [Abstract][Full Text] [Related]
19. [Three Cases of Adenocarcinoma of the Advanced Esophago-Gastric Junction Confirmed as Pathological Complete Response Following Neoadjuvant Chemotherapyand Gastrectomy].
Sato T; Maezawa Y; Kano K; Segami K; Nakajima T; Ikeda K; Aoyama T; Hayashi T; Yamada T; Oshima T; Rino Y; Masuda M; Ogata T; Cho H; Yoshikawa T
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1561-1563. PubMed ID: 28133057
[TBL] [Abstract][Full Text] [Related]
20. [A case showing a complete response by weekly paclitaxel associated with severe empyema and mediastinal abscess caused by reduction of a recurrent lung metastatic tumor originating from adenocarcinoma of the esophagogastric junction after primary operation].
Kimura A; Hiramatsu K; Sakuragawa T; Ito T; Otsuji H; Tsuchiya T; Hara T; Maeda T; Tanaka H; Machiki Y; Hosoya J; Kojima T; Kato K
Gan To Kagaku Ryoho; 2010 Feb; 37(2):303-5. PubMed ID: 20154490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
